OTC Obesity - Denmark
The product category was switched to OTC status in May 2009. There is much public focus on the dangers and growing problem of obesity in Denmark. Consumers therefore showed keen interest in this first medically approved remedy for obesity available without prescription, and sales came off to a good start, reaching DKr2 million by the end of 2009, after only seven months on the market.
Euromonitor International's OTC Obesity Products in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's OTC Obesity Products in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
OTC Obesity in Denmark
Euromonitor International
April 2010
LIST OF CONTENTS AND TABLES
Executive Summary
Health Concerns Were the Key Growth Driver
Competitive Pricing and Wide Distribution Proved Key To Success in 2009
Strong Trend Towards Grocery Retailers
Stagnant Value Sales Forecast
Key Trends and Developments
Liberalization Underpinned Strong Trend Towards Grocery Retailers
Health Concerns was the Key Driver of Consumer Healthcare Demand
Consolidation Strategies Began To Bear Fruit
Dynamic Growth in Internet Retailing
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Summary 2 Research Sources
Actavis Nordic A/S
Strategic Direction
Key Facts
Summary 3 Actavis Nordic A/S: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Actavis Nordic A/S: Competitive Position 2009
Axellus A/S
Strategic Direction
Key Facts
Summary 5 Axellus A/S: Key Facts
Summary 6 Axellus A/S: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Axellus A/S: Competitive Position 2009
Ferrosan A/S
Strategic Direction
Key Facts
Summary 8 Ferrosan A/S: Key Facts
Summary 9 Ferrosan A/S: Operational Indicators
Company Background
Competitive Positioning
Summary 10 Ferrosan A/S: Competitive Position 2009
Nycomed Danmark A/S
Strategic Direction
Key Facts
Summary 11 Nycomed Danmark A/S: Key Facts
Summary 12 Nycomed Danmark A/S: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 13 Nycomed Danmark A/S: Competitive Position 2009
Orifarm A/S
Strategic Direction
Key Facts
Summary 14 Orifarm A/S: Key Facts
Summary 15 Orifarm Group: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 16 Orifarm A/S: Competitive Position 2009
Trends
Category Data
Table 12 Sales of OTC Obesity: Value 2009
Table 13 OTC Obesity Company Shares by Value 2005-2009
Table 14 OTC Obesity Brand Shares by Value 2006-2009
Table 15 Forecast Sales of OTC Obesity: Value 2009-2014
Table 16 Forecast Sales of OTC Obesity: % Value Growth 2009-2014
Euromonitor International
April 2010
LIST OF CONTENTS AND TABLES
Executive Summary
Health Concerns Were the Key Growth Driver
Competitive Pricing and Wide Distribution Proved Key To Success in 2009
Strong Trend Towards Grocery Retailers
Stagnant Value Sales Forecast
Key Trends and Developments
Liberalization Underpinned Strong Trend Towards Grocery Retailers
Health Concerns was the Key Driver of Consumer Healthcare Demand
Consolidation Strategies Began To Bear Fruit
Dynamic Growth in Internet Retailing
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Summary 2 Research Sources
Actavis Nordic A/S
Strategic Direction
Key Facts
Summary 3 Actavis Nordic A/S: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Actavis Nordic A/S: Competitive Position 2009
Axellus A/S
Strategic Direction
Key Facts
Summary 5 Axellus A/S: Key Facts
Summary 6 Axellus A/S: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Axellus A/S: Competitive Position 2009
Ferrosan A/S
Strategic Direction
Key Facts
Summary 8 Ferrosan A/S: Key Facts
Summary 9 Ferrosan A/S: Operational Indicators
Company Background
Competitive Positioning
Summary 10 Ferrosan A/S: Competitive Position 2009
Nycomed Danmark A/S
Strategic Direction
Key Facts
Summary 11 Nycomed Danmark A/S: Key Facts
Summary 12 Nycomed Danmark A/S: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 13 Nycomed Danmark A/S: Competitive Position 2009
Orifarm A/S
Strategic Direction
Key Facts
Summary 14 Orifarm A/S: Key Facts
Summary 15 Orifarm Group: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 16 Orifarm A/S: Competitive Position 2009
Trends
Category Data
Table 12 Sales of OTC Obesity: Value 2009
Table 13 OTC Obesity Company Shares by Value 2005-2009
Table 14 OTC Obesity Brand Shares by Value 2006-2009
Table 15 Forecast Sales of OTC Obesity: Value 2009-2014
Table 16 Forecast Sales of OTC Obesity: % Value Growth 2009-2014